US 12090201
Methods for treating atopic dermatitis by administering an IL-4R antagonist antibody
granted A61KA61K2039/505A61K2039/545
Quick answer
US patent 12090201 (Methods for treating atopic dermatitis by administering an IL-4R antagonist antibody) held by REGENERON PHARMACEUTICALS, INC. expires Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Sep 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K2039/505, A61K2039/545, A61K2039/55, A61K39/3955